Intrathecal treatment of cerebral vasospasm

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 8, 2013, Pages 1201-1211

  Zhang, Yi Ping ^a   Shields, Lisa B E ^a   Yao, Tom L ^a   Dashti, Shervin R ^a   Shields, Christopher B ^a  

^a Norton Healthcare   (United States)

Author keywords

Cerebral aneurysm; nimodipine; tPA; urokinase

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VASODILATOR AGENT;

BLOOD CLOT LYSIS; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CLINICAL TRIAL (TOPIC); CRANIOTOMY; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; HYDROCEPHALUS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; COMPLICATION; INTRASPINAL DRUG ADMINISTRATION; META ANALYSIS; PATHOPHYSIOLOGY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

HUMANS; INJECTIONS, SPINAL; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84889016788     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.04.005     Document Type: Review

References (71)

1. R. Macdonald Cerebral Vasospasm: Advances in Research and Treatment 2005 Thieme New York
2. S. Condette-Auliac, S. Bracard, and R. Anxionnat Vasospasm after subarachnoid hemorrhage: Interest in diffusion-weighted MR imaging Stroke 32 2001 1818 1824
3. W.A. King, and N.A. Martin Critical care of patients with subarachnoid hemorrhage Neurosurg Clin North Am 5 1994 767 787
4. C. Lazaridis, and N. Naval Risk factors and medical management of vasospasm after subarachnoid hemorrhage Neurosurg Clin North Am 21 2010 353 364
5. F. Amenta, A. Lanari, and F. Mignini Nicardipine use in cerebrovascular disease: A review of controlled clinical studies J Neurol Sci 283 2009 219 223
6. J.W. Dankbaar, A.J. Slooter, and G.J. Rinkel Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: A systematic review Crit Care 14 2010 R23
7. L. Tomycz, N. Shekhawat, and J. Forbes The spectrum of management practices in nontraumatic subarachnoid hemorrhage: A survey of high-volume centers in the United States Surg Neurol Int 2 2011 90
8. B. McGuinness, and D. Gandhi Endovascular management of cerebral vasospasm Neurosurg Clin North Am 21 2010 281 290
9. M. Zwienenberg-Lee, J. Hartman, and N. Rudisill Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: Results of a phase II multicenter, randomized, clinical trial Stroke 39 2008 1759 1765
10. N. Kodama, M. Matsumoto, and T. Sasaki Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm Acta Neurochir Suppl 77 2001 171 174
11. T. Sasaki, N. Kodama, and M. Kawakami Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: A study of urokinase concentration and the fibrinolytic system Stroke 31 2000 1256 1262
12. N. Janjua, and S.A. Mayer Cerebral vasospasm after subarachnoid hemorrhage Curr Opin Crit Care 9 2003 113 119
13. C.T. Wu, C.S. Wong, and C.C. Yeh Treatment of cerebral vasospasm after subarachnoid hemorrhage: A review Acta Anaesthesiol Taiwan 42 2004 215 222
14. G.J. Rinkel, V.L. Feigin, and A. Algra Calcium antagonists for aneurysmal subarachnoid haemorrhage Cochrane Database Syst Rev 2005 CD000277
15. G.J. Velat, M.M. Kimball, and J.D. Mocco Vasospasm after aneurysmal subarachnoid hemorrhage: Review of randomized controlled trials and meta-analyses in the literature World Neurosurg 76 2011 446 454
16. R. Gorski, M. Zabek, and P. Jarmuzek Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms Neurol Neurochir Pol 34 2000 41 47
17. H. Kinouchi, K. Ogasawara, and H. Shimizu Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage Neurol Med Chir (Tokyo) 44 2004 569 575
18. J. Ohman, A. Servo, and O. Heiskanen Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage J Neurosurg 75 1991 197 201
19. K. Hirano, and M. Hirano Current perspective on the role of the thrombin receptor in cerebral vasospasm after subarachnoid hemorrhage J Pharmacol Sci 114 2010 127 133
20. Y. Kai, Y. Maeda, and T. Sasaki Basic and translational research on proteinase-activated receptors: the role of thrombin receptor in cerebral vasospasm in subarachnoid hemorrhage J Pharmacol Sci 108 2008 426 432
21. Y. Maeda, K. Hirano, and Y. Kai Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage Br J Pharmacol 152 2007 1131 1139
22. K.L. Koszdin, D.D. Shen, and C.M. Bernards Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration: The role of P-glycoprotein Anesthesiology 92 2000 156 163
23. M. Schurkamper, R. Medele, and S. Zausinger Dexamethasone in the treatment of subarachnoid hemorrhage revisited: A comparative analysis of the effect of the total dose on complications and outcome J Clin Neurosci 11 2004 20 24
24. R.M. Pluta, J.A. Butman, and B. Schatlo Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid: Laboratory investigation J Neurosurg 111 2009 1001 1004
25. I. Gogolak, F. Gotoh, and M. Tomita No intracerebral steal phenomenon in the ischemic brain following papaverine administration Stroke 16 1985 114 117
26. A.H. Kramer, and J.J. Fletcher Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis Neurocrit Care 14 2011 489 499
27. T. Sasaki, T. Ohta, and H. Kikuchi A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage Neurosurgery 35 1994 597 604
28. J.M. Zabramski, R.F. Spetzler, and K.S. Lee Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage J Neurosurg 75 1991 189 196
29. D. Stolke, and V. Seifert Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: Preliminary assessment of efficacy and safety in an open clinical study Neurosurgery 30 1992 877 881
30. J. Hamada, Y. Kai, and M. Morioka Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study Stroke 34 2003 2549 2554
31. K. Yamada, S. Yoshimura, and Y. Enomoto Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage Br J Neurosurg 22 2008 649 653
32. D. Hanggi, S. Eicker, and K. Beseoglu A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: Results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm Cen Eur Neurosurg 70 2009 61 67
33. Y. Kai, K. Ito, and M. Watanabe Development of a kit to treat subarachnoid hemorrhage by intrathecal simple urokinase infusion (ITSUKI) therapy: Preliminary results in patients with World Federation of Neurological Surgery (WFNS) grade V subarachnoid hemorrhage World Neurosurg 75 2011 485 490
34. P.N. Varelas, K.L. Rickert, and J. Cusick Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: Pilot study of treatment with intraventricular tissue plasminogen activator Neurosurgery 56 2005 205 213
35. R. Ramakrishna, L.N. Sekhar, and D. Ramanathan Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage Neurosurgery 67 2010 110 117
36. J.M. Findlay, and M.J. Jacka Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage Neurosurgery 55 2004 532 537
37. K. Goodson, M. Lapointe, and T. Monroe Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage Neurocrit Care 8 2008 247 252
38. D. Hanggi, K. Beseoglu, and B. Turowski Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy Clin Neurol Neurosurg 110 2008 784 790
39. A. Ehtisham, S. Taylor, and L. Bayless Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm South Med J 102 2009 150 153
40. B. Krischek, H. Kasuya, and H. Onda Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: Effect and outcome in the first 100 patients Neurol Med Chir (Tokyo) 47 2007 389 394
41. K. Fujiwara, S. Mikawa, and T. Ebina Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage No Shinkei Geka 29 2001 23 30 (in Japanese)
42. C. Thomé, M. Seiz, and G.A. Schubert Nicardipine pellets for the prevention of cerebral vasospasm Acta Neurochir Suppl 110 2011 209 211
43. K. Mori, T. Yamamoto, and Y. Nakao Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage Neurol Med Chir (Tokyo) 49 2009 139 144
44. A. Agrawal, R. Patir, and Y. Kato Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: A 5-year prospective study with review of the literature Minim Invasive Neurosurg 52 2009 5 8
45. J.E. Thomas, R.H. Rosenwasser, and R.A. Armonda Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans Stroke 30 1999 1409 1416
46. M. Suzuki, M. Doi, and Y. Otawara Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage Neurosurg Rev 24 2001 180 184
47. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
48. S.R. McMechan, and A.A. Adgey Optimal thrombolytic strategies for acute myocardial infarction: Bolus administration QJM 91 1998 719 725
49. S.W. Sharkey, D.D. Bruneete, and E. Ruiz An analysis of time delays preceding thrombolysis for acute myocardial infarction JAMA 262 1989 3171 3174
50. K. Ikeda, H. Asakura, and K. Futami Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage Neurosurgery 41 1997 344 349
51. M. Shibuya, Y. Suzuki, and H. Enomoto Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage Acta Neurochir (Wien) 131 1994 19 25
52. J.E. Thomas, and G. McGinnis Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting Stroke 33 2002 486 492
53. M.G. Lansberg, E. Bluhmki, and V.N. Thijs Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: A meta-analysis Stroke 40 2009 2438 2441
54. W.M. Scheld Drug delivery to the central nervous system: General principles and relevance to therapy for infections of the central nervous system Rev Infect Dis 11 Suppl 7 1989 S1669 S1690
55. M.M. Patel, B.R. Goyal, and S.V. Bhadada Getting into the brain: Approaches to enhance brain drug delivery CNS Drugs 23 2009 35 58
56. M. Einarsson, B. Smedsrod, and H. Pertoft Uptake and degradation of tissue plasminogen activator in rat liver Thromb Haemost 59 1988 474 479
57. D.M. Prevedello, J.G. Cordeiro, and A.L. de Morais Magnesium sulfate: Role as possible attenuating factor in vasospasm morbidity Surg Neurol 65 Suppl 1 2006 S1
58. P. Klimo Jr., J.R. Kestle, and J.D. MacDonald Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage J Neurosurg 100 2004 215 224
59. H.B. Huttner, S. Nagel, and E. Tognoni Intracerebral hemorrhage with severe ventricular involvement: Lumbar drainage for communicating hydrocephalus Stroke 38 2007 183 187
60. P. Jartti, A. Karttunen, and J.M. Isokangas Chronic hydrocephalus after neurosurgical and endovascular treatment of ruptured intracranial aneurysms Acta Radiol 49 2008 680 686
61. R.L. Macdonald Lumbar drainage after subarachnoid hemorrhage: Does it reduce vasospasm and delayed hydrocephalus? Neurocrit Care 7 2007 1 2
62. D.B. Baruah, R.N. Dash, and M.R. Chaudhari Plasminogen activators: A comparison Vascul Pharmacol 44 2006 1 9
63. G.M. Ibrahim, S. Vachhrajani, and D. Ilodigwe Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage Neurosurgery 70 2012 102 109
64. H.D. Garretson, K.H. Reid, and C.B. Shields The effect of topical application of antibiotics on the cerebral cortex: An experimental update J Neurosurg 50 1979 792 797
65. J. Claassen, G.L. Bernardini, and K. Kreiter Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited Stroke 32 2001 2012 2020
66. C.M. Fisher, J.P. Kistler, and J.M. Davis Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning Neurosurgery 6 1980 1 9
67. H. Suzuki, K. Kanamaru, and M. Kuroki Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage Neurol Res 20 1998 625 631
68. D. Hanggi, J. Liersch, and B. Turowski The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: Results of a single-center prospective phase II trial J Neurosurg 108 2008 1192 1199
69. T. Ishida Development of drug delivery system for intrathecal administration and its therapeutic effect on cerebral vasospasm and ischemia Yakugaku Zasshi 124 2004 541 547 (in Japanese)
70. T. Ishida, Y. Takanashi, and H. Kiwada Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil Biol Pharm Bull 29 2006 397 402
71. S. Kawamoto, K. Tsutsumi, and G. Yoshikawa Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage J Neurosurg 100 2004 236 243